» Articles » PMID: 6571990

Oligomeric Structure of Muscarinic Receptors is Shown by Photoaffinity Labeling: Subunit Assembly May Explain High- and Low-affinity Agonist States

Overview
Specialty Science
Date 1983 Jan 1
PMID 6571990
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The potent muscarinic photoaffinity reagent N-methyl-4-piperidyl p-azidobenzilate (azido-4NMPB) was used to covalently label specific muscarinic binding sites in various brain regions and in the heart. In the cortex and hippocampus, a single specifically labeled protein with an apparent molecular mass of 86,000 daltons was detected by gel electrophoresis. In the medulla pons, cerebellum, and cardiac atria, there was a 160,000-dalton band in addition to the 86,000-dalton polypeptide. Under certain conditions, alkali or hydroxylamine treatment dissociated both macromolecules into a single 40,000-dalton polypeptide. These results suggest that the muscarinic receptor exists in oligomeric forms and that a dimer and tetramer of a basic 40,000-dalton peptide may exist as interconvertible species. We propose a model to explain the biological architecture of the muscarinic receptors and suggest a possible correlation between the azido-4NMPB-labeled polypeptides and the two states of the receptor observed in agonist binding experiments.

Citing Articles

G Protein-Coupled Receptor Heteromers as Putative Pharmacotherapeutic Targets in Autism.

DelaCuesta-Barrutia J, Penagarikano O, Erdozain A Front Cell Neurosci. 2020; 14:588662.

PMID: 33192330 PMC: 7662108. DOI: 10.3389/fncel.2020.588662.


Muscarinic receptor oligomerization.

Marsango S, Ward R, Alvarez-Curto E, Milligan G Neuropharmacology. 2017; 136(Pt C):401-410.

PMID: 29146505 PMC: 6078712. DOI: 10.1016/j.neuropharm.2017.11.023.


Smoothened oligomerization/higher order clustering in lipid rafts is essential for high Hedgehog activity transduction.

Shi D, Lv X, Zhang Z, Yang X, Zhou Z, Zhang L J Biol Chem. 2013; 288(18):12605-14.

PMID: 23532857 PMC: 3642308. DOI: 10.1074/jbc.M112.399477.


Receptor oligomerization: from early evidence to current understanding in class B GPCRs.

Ng S, Lee L, Chow B Front Endocrinol (Lausanne). 2013; 3:175.

PMID: 23316183 PMC: 3539651. DOI: 10.3389/fendo.2012.00175.


GPCR oligomers in pharmacology and signaling.

Gonzalez-Maeso J Mol Brain. 2011; 4(1):20.

PMID: 21619615 PMC: 3128055. DOI: 10.1186/1756-6606-4-20.


References
1.
Limbird L, Lefkowitz R . Agonist-induced increase in apparent beta-adrenergic receptor size. Proc Natl Acad Sci U S A. 1978; 75(1):228-32. PMC: 411219. DOI: 10.1073/pnas.75.1.228. View

2.
Birdsall N, BURGEN A, Hulme E . The binding of agonists to brain muscarinic receptors. Mol Pharmacol. 1978; 14(5):723-36. View

3.
Kloog Y, Egozi Y, Sokolovsky M . Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerization. Mol Pharmacol. 1979; 15(3):545-58. View

4.
Hammer R, Berrie C, Birdsall N, BURGEN A, Hulme E . Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 1980; 283(5742):90-2. DOI: 10.1038/283090a0. View

5.
Michaelson D, Avissar S, Kloog Y, Sokolovsky M . Mechanism of acetylcholine release: possible involvement of presynaptic muscarinic receptors in regulation of acetylcholine release and protein phosphorylation. Proc Natl Acad Sci U S A. 1979; 76(12):6336-40. PMC: 411859. DOI: 10.1073/pnas.76.12.6336. View